Connect with us

Health

Under Pressure, Psychology Accreditation Board Suspends Diversity Standards

Published

on

Under Pressure, Psychology Accreditation Board Suspends Diversity Standards

The American Psychological Association, which sets standards for professional training in mental health, has voted to suspend its requirement that postgraduate programs show a commitment to diversity in recruitment and hiring.

The decision comes as accrediting bodies throughout higher education scramble to respond to the executive order signed by President Trump attacking diversity, equity and inclusion policies. It pauses a drive to broaden the profession of psychology, which is disproportionately white and female, at a time of rising distress among young Americans.

The A.P.A. is the chief accrediting body for professional training in psychology, and the only one recognized by the U.S. Department of Education. It provides accreditation to around 1,300 training programs, including doctoral internships and postdoctoral residencies.

Mr. Trump has made accrediting bodies a particular target in his crusade against D.E.I. programs, threatening in one campaign video to “fire the radical Left accreditors that have allowed our colleges to become dominated by Marxist maniacs and lunatics” and “accept applications for new accreditors.”

Department of Justice officials have pressured accrediting bodies in recent weeks, warning the American Bar Association in a letter that it might lose its status unless it repealed diversity mandates. The A.B.A. voted in late February to suspend its diversity and inclusion standard for law schools.

Advertisement

The concession by the A.P.A., a bastion of support for diversity programming, is a particular landmark. The association has made combating racism a central focus of its work in recent years, and in 2021 adopted a resolution apologizing for its role in perpetuating racism by, among other things, promulgating eugenic theories.

Aaron Joyce, the A.P.A.’s senior director of accreditation, said the decision to suspend the diversity requirement was driven by “a large influx of concerns and inquiries” from programs concerned about running afoul of the president’s order.

In many cases, he said, institutions had been instructed by their legal counsels to cease diversity-related activities, and were worried it might imperil their accreditation.

“The Commission does not want to put programs in jeopardy of not existing because of a conflict between institutional guidelines” and accreditation standards, Dr. Joyce said.

He would not describe the tally of the March 13 vote, which followed about three weeks of deliberation. “Nothing about this was an easy decision, and not taken lightly,” he said. “The understanding of individual and cultural diversity is a core facet of the practice of psychology.”

Advertisement

The commission opted to retain another diversity-related standard: Programs must teach trainees to respect cultural and individual differences in order to treat their patients effectively. In reviewing each standard, the commission weighed “what may put programs in a compromised position” against “what is essential to the practice of psychology that simply cannot be changed,” he said.

Kevin Cokley, a professor of psychology at the University of Michigan, said he was “absolutely devastated” to learn of the A.P.A.’s decision on a psychology listserv this week.

“Frankly, I think the decision is really unconscionable, given what we know of the importance of having diverse mental health providers,” Dr. Cokley said. “I don’t know how the A.P.A. can make this sort of decision and think that we are still maintaining the highest standards of training.”

He said he thought the A.P.A. had acted prematurely, and could have waited until it faced a direct challenge from the administration.

“I think that there is always a choice,” he said. “I think this is a classic example of the A.P.A. engaging in anticipatory compliance. They made the move out of fear of what might happen to them.”

Advertisement

According the data from the A.P.A., the psychology work force is disproportionately white. In 2023, more than 78 percent of active psychologists were white, 5.5 percent were Black, 4.4 percent were Asian and 7.8 percent were Latino. (The general population is around 58 percent white, 13.7 percent Black, 6.4 percent Asian and 19.5 percent Latino.)

The demographic breakdown of graduate students in Ph.D. programs, in contrast, is more in line with the country. According to 2022 data from the A.P.A., 54 percent of doctoral students were white, 10 percent were Black, 10 percent were Asian and 11 percent Latino.

John Dovidio, a professor emeritus of psychology at Yale and the author of “Unequal Health: Anti-Black Racism and the Threat to America’s Health,” said the A.P.A.’s focus on diversity in recruiting had played a major part in that change.

“It really is something that departments take very, very seriously,” he said. “I have seen the impact personally.”

A memorandum announcing the decision describes it as an “interim action while awaiting further court guidance” on Mr. Trump’s executive order, which was upheld by a federal court of appeals on March 13. The order, it says, “is currently law while litigation is pending.”

Advertisement

Cynthia Jackson Hammond, the president of the Council for Higher Education Accreditation, which coordinates more than 70 accreditation groups, said it is “unprecedented” for such bodies to receive direct orders from the government.

“The government and higher education have always worked independently, and in good faith with each other,” she said. “Throughout the decades, what we have had is a healthy separation, until now.”

The federal government began taking a role in accreditation after World War II, as veterans flooded into universities under the G.I. Bill. Accrediting bodies are regularly reviewed by the National Advisory Committee on Institutional Quality and Integrity, which advises the Secretary of Education on whether to continue to recognize them.

But government officials have never used this leverage to impose ideological direction on higher education, Ms. Jackson Hammond said. She said diversity in recruitment remains a serious challenge for higher education, which is why the standard is still so commonly used.

“If we think about what our institutions looked like before,” she said, “that might be a barometer of what it’s going to look like if there’s not attention paid.”

Advertisement

Health

Experts Call It 2026’s Best Diet— ‘The Results Are Often Stunning’

Published

on

Experts Call It 2026’s Best Diet— ‘The Results Are Often Stunning’


Advertisement


Best Diet of 2026 Doubles Weight Loss, Burns Belly Fat Fast| Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Deadly ‘superbug’ is spreading across US as drug resistance grows, researchers warn

Published

on

Deadly ‘superbug’ is spreading across US as drug resistance grows, researchers warn

NEWYou can now listen to Fox News articles!

A deadly, drug-resistant fungus already spreading rapidly through U.S. hospitals is becoming even more threatening worldwide, though there may be hope for new treatments, according to a new scientific review.

Candida auris (C. auris), often described as a “superbug fungus,” is spreading globally and increasingly resisting human immune systems, Hackensack Meridian Center for Discovery and Innovation (CDI) researchers said in a review published in early December.

The findings reinforce prior CDC warnings that have labeled C. auris an “urgent antimicrobial threat” — the first fungal pathogen to receive that designation — as U.S. cases have surged, particularly in hospitals and long-term care centers.

DANGEROUS SPIKE IN SUPERBUG INFECTIONS SURGES ACROSS US AS EXPERTS SHARE CAUTIONS

Advertisement

Approximately 7,000 cases were identified across dozens of U.S. states in 2025, according to the CDC, and it has reportedly been identified in at least 60 countries.

Candida auris is a drug-resistant fungus spreading in hospitals worldwide. (Nicolas Armer/Picture Alliance via Getty Images)

The review, published in Microbiology and Molecular Biology Reviews, helps explain why the pathogen is so difficult to contain and warns that outdated diagnostics and limited treatments lag behind. It was conducted by Dr. Neeraj Chauhan of the Hackensack Meridian CDI in New Jersey, Dr. Anuradha Chowdhary of the University of Delhi’s Medical Mycology Unit and Dr. Michail Lionakis, chief of the clinical mycology program at the National Institutes of Health.

Their findings stress the need to develop “novel antifungal agents with broad-spectrum activity against human fungal pathogens, to improve diagnostic tests and to develop immune- and vaccine-based adjunct modalities for the treatment of high-risk patients,” the researchers said in a statement.

GROWING ANTIBIOTIC CRISIS COULD TURN BACTERIAL INFECTIONS DEADLY, EXPERTS WARN

Advertisement

“In addition, future efforts should focus on raising awareness about fungal disease through developing better surveillance mechanisms, especially in resource-poor countries,” they added. “All these developments should help improve the outcomes and prognosis of patients afflicted by opportunistic fungal infections.”

Candida auris can survive on skin and hospital surfaces, allowing it to spread easily. (iStock)

First identified in 2009 from a patient’s ear sample in Japan, C. auris has since spread to dozens of countries, including the U.S., where outbreaks have forced some hospital intensive care units to shut down, according to the researchers.

The fungus poses the greatest risk to people who are already critically ill, particularly those on ventilators or with weakened immune systems. Once infected, about half of patients may die, according to some estimates.

FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST

Advertisement

Unlike many other fungi, C. auris can survive on human skin and cling to hospital surfaces and medical equipment, allowing it to spread easily in healthcare settings.

“It is resistant to multiple antifungal drugs, and it tends to spread in hospital settings, including on equipment being used on immunocompromised and semi-immunocompromised patients, such as ventilators and catheters,” Dr. Marc Siegel, Fox News senior medical analyst and clinical professor of medicine at NYU Langone, previously told Fox News Digital.

Scientists say the unique cell wall structure of C. auris makes it harder to kill. (iStock)

It is also frequently misdiagnosed, delaying treatment and infection control measures.

Advertisement

“Unfortunately, symptoms such as fever, chills and aches may be ubiquitous, and it can be mistaken for other infections,” Siegel said.

In September, he said intense research was ongoing to develop new treatments.

Only four major classes of antifungal drugs are currently available, and C. auris has already shown resistance to many of them. While three new antifungal drugs have been approved or are in late-stage trials, researchers warn that drug development has struggled to keep pace with the fungus’s evolution.

CLICK HERE FOR MORE LIFESTYLE STORIES

Despite the sobering findings, there is still room for cautious optimism.

Advertisement

The fungus can cling to skin and hospital surfaces, aiding its spread. (iStock)

In separate research published in December, scientists at the University of Exeter in England discovered a potential weakness in C. auris while studying the fungus in a living-host model. 

The team found that, during infection, the fungus activates specific genes to scavenge iron, a nutrient it needs to survive, according to their paper, published in the Nature portfolio journal Communications Biology in December.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Because iron is essential for the pathogen, researchers believe drugs that block this process could eventually stop infections or even allow existing medications to be repurposed.

Advertisement

“We think our research may have revealed an Achilles’ heel in this lethal pathogen during active infection,” Dr. Hugh Gifford, a clinical lecturer at the University of Exeter and co-author of the study, said in a statement.

New research is underway to develop better treatments and diagnostics for C. auris. (iStock)

As researchers race to better understand the fungus, officials warn that strict infection control, rapid detection and continued investment in new treatments remain critical.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Health experts emphasize that C. auris is not a threat to healthy people.

Advertisement

Fox News Digital has reached out to the CDI researchers and additional experts for comment.

Fox News Digital’s Angelica Stabile contributed reporting.

Advertisement
Continue Reading

Health

Record-breaking flu numbers reported in New York state, sparking warnings from officials

Published

on

Record-breaking flu numbers reported in New York state, sparking warnings from officials

NEWYou can now listen to Fox News articles!

The New York State Department of Health reported a record surge in influenza activity, with 71,123 positive flu cases recorded statewide during the week ending December 20.

Advertisement

Health officials said the figure represents the highest number of flu cases ever reported in a single week since influenza became a reportable disease in New York in 2004.

State health data show the weekly total reflects a 38% increase from the previous reporting period, signaling a rapidly intensifying flu season.

There have been 189,312 reported positive flu cases so far this season, while influenza-related hospitalizations rose 63% in the most recent week.

FLU BY STATE: WHERE THIS SEASON’S HIGHLY CONTAGIOUS VARIANT IS SPREADING THE MOST

New York reported the highest weekly total of cases ever recorded since influenza became reportable in 2004. (iStock)

Advertisement

“We are seeing the highest number of flu cases ever recorded in a single week in New York state,” Health Commissioner Dr. James McDonald said in a press release.

There have been 189,312 reported flu cases so far this season, with influenza-related hospitalizations increasing 63% in the most recent week. (iStock)

Earlier this month, the department declared influenza prevalent statewide, a designation that requires unvaccinated health care workers to wear masks in patient care settings.

SURGE IN WHOOPING COUGH CASES IN SOUTHERN STATE PROMPTS HEALTH ALERTS

Health officials continue to emphasize that vaccination remains the most effective way to prevent severe illness and hospitalization from influenza.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

New Yorkers who have not yet received a seasonal flu shot are still encouraged to do so, with experts saying vaccination can offer protection even later in the season.

Health officials continue to urge New Yorkers to take preventive steps, including vaccination and staying home when sick, to limit further spread. (iStock)

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

To help limit further spread, the department advises individuals experiencing flu-like symptoms — including fever, cough, sore throat, or body aches — to stay home. State health officials also recommend frequent handwashing, using hand sanitizer, and avoiding close contact with sick individuals.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

For those who become ill, officials say antiviral medications are available and are most effective when started within 48 hours of symptom onset.

Health officials also added that people at higher risk for complications should contact a health care provider promptly for evaluation and possible treatment.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The department noted that flu activity typically peaks in January, meaning case counts could continue to climb in the weeks ahead.

Advertisement

Continue Reading
Advertisement

Trending